UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of November, 2014
 
Commission File Number 000-26495
 
CYREN Ltd.
(Translation of Registrant’s name into English)
 
1 Sapir Road, 5th Floor, Beit Ampa, P.O. Box 4014, Herzliya 46140, Israel
(Address of Principal Executive Offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F x   Form 40-F o
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):___
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):___
 
 
 

 
 
On November 18, 2014, the Registrant issued a press release announcing its third quarter 2014 financial results for the period ending September 30, 2014.
 
A copy of the press release is annexed hereto as Exhibit 1 and incorporated herein by reference.
 
 
 

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
CYREN Ltd.
(Registrant)
 
       
Date: November 18, 2014
By:
/s/ J. Michael Myshrall
 
   
J. Michael Myshrall
 
   
Chief Financial Officer
 
       
 


 
 

 




Exhibit 1
 
   PRESS RELEASE
 
CYREN Reports Third Quarter 2014 Results
 
McLean, VA – November 18, 2014 – CYREN Ltd. (NASDAQ: CYRN), a global provider of cloud-based cybersecurity solutions, today announced its third quarter 2014 financial results for the period ending September 30, 2014.

Third Quarter 2014 Financial Highlights:

 
·
Revenues in accordance with U.S. Generally Accepted Accounting Principles (US GAAP) totaled $7.7 million for the third quarter of 2014 compared to $8.0 million in the third quarter of 2013.

 
·
Non-GAAP revenues totaled $7.8 million for the third quarter of 2014 compared to $8.1 million in the third quarter of 2013. The difference between non-GAAP and GAAP revenue is derived from the fact that deferred revenues consolidated from acquired companies are accounted under GAAP based on fair value.

 
·
GAAP net loss for the third quarter of 2014 was $0.7 million compared to a net loss of $0.9 million in the third quarter of 2013.
 
 
·
GAAP loss per basic and diluted share for the third quarter of 2014 was $0.02, compared to a loss of $0.03 in the third quarter of 2013.

 
·
Non-GAAP net loss for the third quarter 2014 was $0.7 million compared to non-GAAP net income of $0.3 million in the third quarter of 2013.
 
 
·
Non-GAAP loss per basic and diluted share for the third quarter 2014 was $0.02, compared to non-GAAP earnings per diluted share of $0.01 in the third quarter of 2013.

 
·
Cash used by operating activities during the quarter was $0.1 million. Net cash provided by financing activities during the quarter was $10.2 million.

 
·
Cash as of September 30, 2014 was $13.1 million, compared to $3.1 million as of June 30, 2014. In addition, the company had drawn $5.3 million under its $7.5 million credit facility. The increase in cash primarily reflects the $10.2 million in net proceeds CYREN raised in a registered direct offering that closed on July 30, 2014.
 
“CYREN remains in a strong financial position with the revenue generated from our embedded business and the capital raised in July. We see particularly strong demand from enterprise customers for our embedded solutions and strong interest in our cloud-based CYREN WebSecurity offering,” said Lior Samuelson, CEO and Chairman of the Board at CYREN. “We continue work with our increasing number of channel partners to accelerate the onboarding process and revenue growth. We are also focusing resources on enterprises who are actively seeking to replace or augment their existing security appliances with a next generation SaaS-based solution.”
 
 

 
 
 
For information regarding the non-GAAP financial measures discussed in this release, please see “Use of Non-GAAP Financial Information” and “Reconciliation of Selected GAAP Measures to Non GAAP Measures.”
 
Business Highlights:

·
CYREN completed a registered direct offering, which was oversubscribed and brought in $11.5 million in gross proceeds, strengthening the company’s balance sheet and giving it the ability to further execute its growth strategy.
 
·
Tesco, a leading retailer in the United Kingdom, will use the company’s Embedded URL Filtering product in a new version of an Android tablet being released ahead of the holiday season. This is one of the first times CYREN’s URL filtering solutions will be embedded in an Android device.
 
·
CYREN extended its contract with ATOS Germany to provide the company’s EmailSecurity solution to large enterprise customers. The renewed contract will run through mid-2018. CYREN is also working with ATOS Germany to expand their partnership to include reselling the WebSecurity and EmailSecurity SaaS solutions.
 
·
CYREN signed a three-year deal to provide embedded AntiSpam and Outbound AntiSpam solutions to one of the largest security technology companies in the world. This supplements two other CYREN contracts with this company that utilize CYREN’s embedded Antivirus solutions.
 
·
During the third quarter, the company increased the number of CYREN WebSecurity partners to 24 (up from 18 at the end of the second quarter), including distributors and resellers in 18 countries.
 
Business Outlook

The company expects fourth quarter revenues to be at similar levels as the third quarter, and full year 2014 revenue to be flat to slightly down compared with 2013. The above outlook is as of the date of this release, and the company undertakes no obligation to update its estimates in the future.

Use of Non-GAAP Measures
 
Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: stock-based compensation expenses, amortization and impairment of acquired intangible assets, executive termination costs, deferred taxes and deferred revenues related to acquisitions, acquisition related costs, onetime settlement agreements, reorganization expenses and adjustments to earn-out obligations. The purpose of such adjustments is to give an indication of the company’s performance exclusive of non-cash charges and other items that are considered by management to be outside of the company’s core operating results. The company’s non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with the company’s consolidated financial statements prepared in accordance with GAAP. Company management regularly uses supplemental non-GAAP financial measures internally to understand, manage and evaluate the business and make operating decisions.
 
 

 

These non-GAAP measures are among the primary factors management uses in planning for and forecasting future periods. The company believes this adjustment is useful to investors as a measure of the ongoing performance of the business. The company believes these non-GAAP financial measures provide consistent and comparable measures to help investors understand the company’s current and future operating cash flow performance. These non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table immediately following the Consolidated Statements of Income. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management uses both GAAP and non-GAAP measures when evaluating the business internally and therefore felt it important to make these non-GAAP adjustments available to investors.

Financial Results Conference Call
 
The company has scheduled a conference call later today, November 18, 2014, at 10 a.m. Eastern Time (5 p.m. Israel Time) to discuss its third quarter 2014 results.

To participate, please call one of the following teleconferencing numbers by dialing in at least 10 minutes before the conference call commences. If you are unable to connect using the toll-free numbers, please try the international dial-in number.

US Dial-in Number: 1-877-675-4753
Israel Dial-in Number: 1-80-925-8243
International Dial-in Number: 1-719-325-4751

The call will be simultaneously webcast live on the investor relations section of CYREN’s website at http://www.cyren.com/ir.html.

For those unable to listen to the live call, a webcast replay of the call will be available from the day after the call in the investor relations section of CYREN’s corporate website.

About CYREN
CYREN is a leading provider of cloud-based security solutions that deliver powerful protection through global data intelligence. Regardless of the device or its location, CYREN's easily deployed web, email, and anti-malware products deliver uncompromising protection in both embedded and Security as a Service (SecaaS) deployments. Organizations rely on CYREN's cloud-based threat detection and proactive security analytics to provide up-to-date spam classifications, URL categorization and malware detection services. The CYREN GlobalView™ Cloud Platform leverages Recurrent Pattern Detection™ technologies to protect more than 550 million users in 190 countries. CYREN is traded on the NASDAQ Capital Market and the Tel Aviv Stock Exchange (TASE) under the trading symbol "CYRN." Visit the CYREN GlobalView Security Center or go to www.CYREN.com.

Blog: blog.cyren.com
Facebook: www.facebook.com/CyrenWeb
LinkedIn: www.linkedin.com/company/cyren
Twitter: www.twitter.com/CyrenInc

Blog: blog.cyren.com
Facebook: www.facebook.com/CyrenWeb
LinkedIn: www.linkedin.com/company/cyren
Twitter: www.twitter.com/CyrenInc
 
 

 

This press release contains forward-looking statements, including projections about the company’s business, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. For example, statements in the future tense, and statements including words such as "expect," "plan," "estimate," "anticipate," or "believe" are forward-looking statements. These statements are based on information available at the time of the press release and the company assumes no obligation to update any of them. The statements in this press release are not guarantees of future performance and actual results could differ materially from current expectations as a result of numerous factors, including business conditions and growth or deterioration in the internet security market, technological developments, products offered by competitors, availability of qualified staff, and technological difficulties and resource constraints encountered in developing new products, as well as those risks described in the company's Annual Reports on Form 20-F, reports on Form 6-K and prospectus supplement dated July 24, 2014 and prospectus dated July 3, 2014 filed pursuant to Rule 424(b)(2, which are available through www.sec.gov.  
 
U.S. Investor Contact
Garth Russell
KCSA Strategic Communications
+1 212 896 1250
grussell@kcsa.com
 
Israel Investor Contact
Iris Lubitch
EffectiveIR
+972 54 2528007
iris@FinCom.co.il

Company Contact:
Mike Myshrall, CFO
CYREN
+1 703 760 3320
mike.myshrall@CYREN.com

Media Contact
Matthew Zintel
Zintel Public Relations
+1 281 444 1590
matthew.zintel@zintelpr.com
 
 
 

 
 
CYREN LTD.
 
 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in  thousands of U.S. dollars, except per share amounts)
 
   
Three months ended
   
Nine months ended
 
   
September 30
   
September 30
 
 
 
2014
   
2013
   
2014
   
2013
 
   
Unaudited
   
Unaudited
   
Unaudited
   
Unaudited
 
                         
 Revenues
  $ 7,731     $ 8,019     $ 24,083     $ 23,999  
                                 
 Cost of revenues
    2,037       1,722       6,124       5,256  
                                 
Gross profit
    5,694       6,297       17,959       18,743  
                                 
Operating expenses:
                               
                                 
 Research and development, net
    2,417       2,079       8,398       6,525  
                                 
 Sales and marketing
    2,821       2,559       8,950       7,861  
                                 
 General and administrative
    1,624       2,112       5,773       6,590  
                                 
 Adjustment of earnout obligation
    (701 )     -       (701 )     -  
                                 
 Total operating expenses
    6,161       6,750       22,420       20,976  
                                 
Operating loss
    (467 )     (453 )     (4,461 )     (2,233 )
                                 
Other income
    -       -       200       -  
                                 
Financial  expense, net
    (249 )     (323 )     (712 )     (866 )
                                 
Net loss before taxes
    (716 )     (776 )     (4,973 )     (3,099 )
                                 
Tax benefit (expense)
    (7 )     (138 )     113       181  
                                 
Net loss
  $ (723 )   $ (914 )   $ (4,860 )   $ (2,918 )
                                 
Loss per share - basic
  $ (0.02 )   $ (0.03 )   $ (0.18 )   $ (0.11 )
                                 
Loss per share - diluted
  $ (0.02 )   $ (0.03 )   $ (0.18 )   $ (0.11 )
                                 
Weighted average number of shares outstanding:
                         
Basic
    29,806       26,384       27,646       26,150  
Diluted
    29,806       26,384       27,646       26,150  

 
 

 
CYREN LTD.
 
RECONCILIATION OF SELECTED GAAP MEASURES TO NON GAAP MEASURES
(in  thousands of U.S.dollars, except per share amounts)
 
   
Three months ended
   
Nine months ended
 
   
September 30
   
September 30
 
 
 
2014
   
2013
   
2014
   
2013
 
   
Unaudited
   
Unaudited
   
Unaudited
   
Unaudited
 
                         
GAAP operating loss
  $ (467 )   $ (453 )   $ (4,461 )   $ (2,233 )
Stock-based compensation (1)
    294       329       955       1,003  
Other acquisition related costs (2)
    -       -       -       142  
Amortization of intangible assets (3)
    436       542       1,327       1,307  
Adjustment to earn-out liabilities (4)
    (701 )     -       (701 )     (3 )
Executive terminations (6)
    -       -       208       165  
Adjustment to deferred revenues (7)
    50       74       154       412  
Settlement agreements (8)
    -       16       -       91  
Re organization expenses (9)
    -       96       75       96  
                                 
Non-GAAP operating profit (loss)
  $ (388 )   $ 604     $ (2,443 )   $ 980  
                                 
GAAP net loss
  $ (723 )   $ (914 )   $ (4,860 )   $ (2,918 )
Stock-based compensation (1)
    294       329       955       1,003  
Other acquisition related costs (2)
    -       -       -       142  
Amortization of intangible assets (3)
    436       542       1,327       1,307  
Adjustment to earn-out liabilities (4)
    (638 )     271       (449 )     703  
Income taxes (5)
    (103 )     (92 )     (317 )     (464 )
Executive terminations (6)
    -       -       208       165  
Adjustment to deferred revenues (7)
    50       74       154       412  
Settlement agreements (8)
    -       16       (200 )     91  
Reorganization expenses (9)
    -       96       75       96  
                                 
Non-GAAP net income (loss)
  $ (684 )   $ 322     $ (3,107 )   $ 537  
                                 
GAAP loss per share (dilluted)
    (0.02 )     (0.03 )     (0.17 )     (0.11 )
Stock-based compensation (1)
    0.01       0.01       0.03       0.04  
Other acquisition related costs (2)
    0.00       0.00       0.00       0.01  
Amortization of intangible assets (3)
    0.01       0.02       0.05       0.05  
Adjustment to earn-out liabilities (4)
    (0.02 )     0.01       (0.02 )     0.03  
Income taxes (5)
    (0.00 )     (0.00 )     (0.01 )     (0.02 )
Executive terminations (6)
    0.00       0.00       0.01       0.01  
Adjustment to deferred revenues (7)
    0.00       0.00       0.01       0.02  
Settlement agreements (8)
    0.00       0.00       (0.01 )     0.00  
Reorganization expenses (9)
    0.00       0.00       0.00       0.00  
                                 
Non-GAAP earnings (loss) per share (diluted)
    (0.02 )     0.01       (0.11 )     0.03  
                                 
Numbers of shares used in computing non-GAAP earnings per share (diluted)
    29,806       26,445       27,646       26,277  
                                 
(1) Stock-based compensation
                               
 Cost of revenues
  $ 15     $ 12     $ 40     $ 38  
 Research and development
    82       64       229       185  
 Sales and marketing
    72       51       216       186  
 General and administrative
    125       202       470       594  
                                 
    $ 294     $ 329     $ 955     $ 1,003  
(2) Other acquisition related costs
                               
General and administrative
  $ -     $ -     $ -     $ 142  
                                 
    $ -     $ -     $ -     $ 142  
(3) Amortization of intangible assets
                               
 Cost of revenues
  $ 211     $ 235     $ 644     $ 564  
 Sales and marketing
    225       307       683       743  
                                 
    $ 436     $ 542     $ 1,327     $ 1,307  
(4) Adjustment to earn-out liabilities
                               
 General and administrative
  $ (701 )   $ -     $ (701 )   $ (3 )
Financial expenses, net
    63       271       252       706  
                                 
    $ (638 )   $ 271     $ (449 )   $ 703  
(5) Income taxes
                               
Deferred tax asset - tax benefit
  $ (103 )   $ (92 )   $ (317 )   $ (464 )
                                 
    $ (103 )   $ (92 )   $ (317 )   $ (464 )
(6) Executive terminations
                               
General and administrative
  $ -     $ -     $ 208     $ 165  
                                 
    $ -     $ -     $ 208     $ 165  
(7) Adjustment to deferred revenues
                               
Revenues
  $ 50     $ 74     $ 154     $ 412  
                                 
    $ 50     $ 74     $ 154     $ 412  
(8) Settlement agreements
                               
General and administrative
  $ -     $ 16     $ -     $ 91  
Other income
    -       -       (200 )     -  
                                 
    $ -     $ 16     $ (200 )   $ 91  
                                 
(9) Reorganization expenses
                               
General and administrative
  $ -     $ 96     $ 75     $ 96  
                                 
    $ -     $ 96     $ 75     $ 96  
 
 
 

 
 
CYREN LTD.
 
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands of U.S. dollars)
 
   
September 30
   
December 31
 
 
 
2014
   
2013
 
   
Unaudited
   
Audited
 
             
                 Assets
           
    Current Assets:
           
Cash and cash equivalents
  $ 13,094     $ 3,757  
Trade receivables, net
    4,085       5,178  
Deferred tax assets
    -       48  
Prepaid expenses and other receivables
    1,417       1,988  
Total current assets
    18,596       10,971  
                 
Lease deposits
    75       74  
Severance pay fund
    635       819  
Property and equipment, net
    2,546       2,674  
Goodwill and intangible assets, net
    33,009       36,395  
Total long-term assets
    36,265       39,962  
                 
Total assets
  $ 54,861     $ 50,933  
                 
                 Liabilities and Shareholders’ Equity
               
    Current Liabilities:
               
Credit line
  $ 5,347     $ 3,245  
Trade payables
    638       859  
Employees and payroll accruals
    2,366       3,102  
Deferred tax liability
    149       -  
Accrued expenses and other liabilities
    1,233       1,366  
Earn-out consideration
    2,294       1,428  
Deferred revenues
    4,407       4,499  
Total current liabilities
    16,434       14,499  
                 
Deferred revenues
    1,238       1,646  
Deferred tax liability
    2,150       2,749  
Earn-out consideration
    903       2,857  
Accrued severance pay
    706       873  
Total long-term liabilities
    4,997       8,125  
                 
Shareholders’ equity
    33,430       28,309  
Total liabilities and shareholders’ equity
  $ 54,861     $ 50,933  
 
 
 

 
 
CYREN LTD.
 
 CONDENSED CONSOLIDATED CASH FLOW DATA
(in thousands of U.S. dollars)
 
   
Three months ended
   
Nine months ended
 
   
September 30
   
September 30
 
   
2014
   
2013
   
2014
   
2013
 
Cash flows from operating activities:
 
Unaudited
   
Unaudited
   
Unaudited
   
Unaudited
 
                         
Net loss
  $ (723 )   $ (914 )   $ (4,860 )   $ (2,918 )
                                 
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
                               
Loss on disposal of property and equipment
    (1 )     -       (1 )     -  
Depreciation
    313       361       955       858  
Stock based compensation
    294       329       955       1,003  
Amortization of intangible assets
    436       542       1,327       1,307  
Accrued interest, accretion of discount and exchange rate differences on credit line
    46       110       102       108  
Accretion and change in fair value of earn-out consideration, net
    (638 )     271       (449 )     702  
                                 
Changes in assets and liabilities:
                               
Trade receivables
    823       (611 )     1,181       201  
Deferred taxes
    (65 )     (92 )     (184 )     (464 )
Prepaid expenses and other receivables
    (59 )     67       476       (935 )
Trade payables
    (134 )     (406 )     (392 )     (318 )
Employees and payroll accruals, accrued expenses and other liabilities
    (211 )     37       (709 )     (479 )
Deferred revenues
    (121 )     (624 )     (531 )     1,334  
Accrued severance pay, net
    (10 )     (50 )     17       (59 )
Net cash provided by (used in) operating activities
    (50 )     (980 )     (2,113 )     340  
                                 
Cash flows from investing activities:
                               
                                 
Change in long-term lease deposits
    2       (20 )     (3 )     (26 )
Proceeds from sale of fixed assets
    -       4       -       4  
Investment in affiliate
    -       -       -       (80 )
Purchase of property and equipment
    (145 )     (320 )     (703 )     (1,656 )
Net cash used in investing activities
    (143 )     (336 )     (706 )     (1,758 )
                                 
Cash flows from financing activities:
                               
                                 
Proceeds from capital issuance, net
    10,238       -       10,238       -  
Proceeds from credit line
    -       -       2,000       3,005  
Payment of earn-out consideration
    -       -       (351 )     (3,994 )
Proceeds from options exercised
    3       297       331       1,216  
Net cash provided by financing activities
    10,241       297       12,218       227  
Effect of exchange rate changes on cash and cash equivalents
    (58 )     40       (62 )     26  
Increase (decrease) in cash and cash equivalents
    10,048       (1,019 )     9,399       (1,191 )
Cash and cash equivalents at the beginning of the period
    3,104       4,951       3,757       5,137  
Cash and cash equivalents at the end of the period
  $ 13,094     $ 3,972     $ 13,094     $ 3,972  
                                 


CYREN (NASDAQ:CYRN)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more CYREN Charts.
CYREN (NASDAQ:CYRN)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more CYREN Charts.